MedPath
NMPA Approval

Rifamycin Sodium Injection

国药准字H20063561

May 18, 2020

Drug Information

利福霉素钠注射液

注射剂

5ml:0.25g(25万单位)

化学药品

May 18, 2020

Company Information

Applicant Company

Manufacturing Company

海南省海口市海口国家高新技术产业开发区药谷一路4号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

利福霉素钠注射液 - NMPA 批准文号 | MedPath